Decreased EPCR expression and EPCR shedding occurs in inflammatory bowel disease (95), malaria (96), diabetes (97), lupus, cardiovascular ischemia–reperfusion injury (98), and endotoxemia (99). This evidence concerns the gene PROCR and serum lipopolysaccharide activity.